Yifeng Xu

TL;DR: This study is the first nationwide large-scale survey of psychological distress in the general population of China during the COVID-19 epidemic, which triggered a wide variety of psychological problems, including panic disorder, anxiety and depression.

TL;DR: In this paper, a mixture for treating panasthenia, which comprises the following raw material medicaments in part by weight: 13 to 17 parts of tuber fleeceflower stem, 13 to17 parts of silk tree albizzia bark, 1 to 5 parts of grassleaf sweelflag rhizome, 13 To 17 parts, hairyvein agrimonia herb and bud, 13 TO 17 parts coral ardisia root, 13To 17 part of fragrant solomonseal rhizOME, young leonurus and 13 TO 16 parts of sp

TL;DR: In this paper, an angelica sinensis chengqi decoction which is prepared from the following bulk pharmaceutical chemicals in parts by weight: 400-800 parts of rheum officinale, 200-400 parts of mirabilite, 400- 800 parts of angelica sensis, 200 -300 parts of pericarpium citri reticulatae, 140-180 parts of snakegourd seed, 60-100 parts of snakeskin peel, and 1-2 parts of ethylparaben.

TL;DR: In this article, a mixture for treating depression is described, which is prepared from the following bulk pharmaceutical chemicals in parts by weight: 88-128 parts of radix bupleuri, 88- 128 parts of dragon's bones, 160-200 parts of concha ostreae and 70-110 parts of mirabilite.

TL;DR: In this paper, a drug for treating neurasthenia, insomnia, dreaminess, anxiety and forgetfulness was proposed, and the drug was prepared from the following pharmaceutical raw materials in parts by weight: 18-22 parts of tuber fleeceflower stem, 18- 22 parts of silktree albizzia bark, 3-7 parts of grassleaf sweelflag rhizome, 18 -22 parts and bud of hairyvein agrimonia herb and bud, 18 22 parts Japanese ardisia herb, 18 − 22 parts fragrant solomonseal